Not applicableAvailableNCT04159597What this trial is testingExpanded Access to UpadacitinibWho this might be right forCrohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+11 more AbbVie
Testing effectiveness (Phase 2)Study completedNCT03288324What this trial is testingOpen-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With LupusWho this might be right forCutaneous LupusSystemic Lupus Erythematosus Children's Hospital Medical Center, Cincinnati 13
Large-scale testing (Phase 3)Study completedNCT00000420What this trial is testingSafety of Estrogens in Lupus: Birth Control PillsWho this might be right forSystemic Lupus Erythematosus NYU Langone Health 350
Testing effectiveness (Phase 2)Looking for participantsNCT05538208What this trial is testingThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyWho this might be right forLupus Nephritis Children's Hospital Medical Center, Cincinnati 105
Early research (Phase 1)UnknownNCT06316076What this trial is testingSafety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more RenJi Hospital 48
Very early researchWithdrawnNCT06866080What this trial is testingLCAR-AIO in Subjects With Relapsed/Refractory Autoimmune DiseasesWho this might be right forRelapsed/Refractory Autoimmune Diseases Nanjing Legend Biotech Co.
Very early researchLooking for participantsNCT06497361What this trial is testingSafety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related DiseaseWho this might be right forLupus NephritisIgG4-related Disease Tongji Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06350110What this trial is testingFourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more Essen Biotech 75
Not applicableActive Not RecruitingNCT05715463What this trial is testingRheumatology-based Adaptive Intervention for Social Determinants and Health EquityWho this might be right forRheumatoid ArthritisPalindromic ArthritisJuvenile Rheumatoid Arthritis+11 more Brigham and Women's Hospital 101
Large-scale testing (Phase 3)Active Not RecruitingNCT05617677What this trial is testingAssess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Bristol-Myers Squibb 516
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187What this trial is testingStudy to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Kira Pharmacenticals (US), LLC. 24
Not applicableUnknownNCT05516511What this trial is testingSerum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous PatientsWho this might be right forSystemic Lupus Erythematosus Sohag University 75
Post-approval studies (Phase 4)Looking for participantsNCT05559671What this trial is testingSafety of the Herpes Zoster Subunit Vaccine in LupusWho this might be right forSystemic Lupus Erythematosus NYU Langone Health 224
Early research (Phase 1)Study completedNCT06150651What this trial is testingSafety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.Who this might be right forSLE (Systemic Lupus) Chulalongkorn University 3
Large-scale testing (Phase 3)Looking for participantsNCT06133972What this trial is testingPhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).Who this might be right forSystemic Lupus Erythematosus Novartis Pharmaceuticals 550
Post-approval studies (Phase 4)UnknownNCT05666336What this trial is testingMulti-omics Studies on the Efficacy of Telitacicept in Chinese SLE PatientsWho this might be right forSystemic Lupus Erythematosus Fen Li 30
Not applicableEnded earlyNCT03937856What this trial is testingSmartphone Mindfulness Meditation for Patients With Rheumatic DiseasesWho this might be right forInflammatory ArthritisSclerodermaMyositis+3 more Johns Hopkins University 49
Early research (Phase 1)Study completedNCT04136145What this trial is testingSingle Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy SubjectsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 36
Testing effectiveness (Phase 2)Ended earlyNCT02682407What this trial is testingSafety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721Who this might be right forIgANLNMN+1 more Omeros Corporation 31
Testing effectiveness (Phase 2)Study completedNCT05430087What this trial is testingVitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus PatientsWho this might be right forSystemic Lupus Erythematosus Saiful Anwar Hospital 45